Celanese Corporation (CE)

NYSE


	Symbol		Exchange		Currency
	CE		NYSE		USD	Real-time
	DG3		TradeGate		EUR	Delayed
	C1NS34		B3		BRL	Delayed

Currency in USD

Disclaimer

136.67

+2.77(+2.07%)

Closed05:59:59

After Hours

136.670.00(0.00%)

06:02:09

Fair Value

Day's Range

135.46

137.38

52 wk Range

110.76

172.16

CE Income Statement

Featured here, the Income Statement (earnings report) for Celanese Corporation, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Total Revenues

6,297

5,655

8,537

9,673

10,940

Total Revenues Growth

-11.99%

-10.2%

+50.96%

+13.31%

+13.1%

Cost Of Revenues

4,691

4,362

5,855

7,293

8,337

Gross Profit

1,606

1,293

2,682

2,380

2,603

Gross Profit Growth

-18.56%

-19.49%

+107.42%

-11.26%

+9.37%

Gross Profit Margin %

25.5%

22.86%

31.42%

24.6%

23.79%

Other Operating Expenses, Total

593

559

638

864

1,454

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-15.53%	-5.73%	+14.13%	+35.42%	+68.29%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	67	74	86	112	146
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	502	464	527	690	1,144
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-1	-	-	-

Operating Income

1,013

734

2,044

1,516

1,149

Operating Income Growth

-20.24%

-27.54%

+178.47%

-25.83%

-24.21%

EBIT Margin %

16.09%

12.98%

23.94%

15.67%

10.5%

Net Interest Expenses

4

23

64

-203

-555

Net Interest Expenses Growth

+300%

+475%

+178.26%

-417.19%

-173.4%

Interest Expense, Total

-115

-109

-91

-405

-720

Interest And Investment Income

119

132

155

202

165

Other Non Operating Expenses, Total

181

134

143

228

159

EBT, Excl. Unusual Items

1,198

891

2,251

1,541

753

Gain (Loss) On Sale Of Assets

-2

-7

3

5

505

Other Unusual Items, Total

-98

-28

-11

-14

-22

EBT, Incl. Unusual Items

988

2,251

2,248

1,421

1,183

EBT, Incl. Unusual Items Growth

-34.57%

+127.83%

-0.13%

-36.79%

-16.75%

EBT, Incl. Unusual Items Margin

15.69

39.81

26.33

14.69

10.81

Income Tax Expense

124

247

330

-489

-790

Net Income to Company

858

1,992

1,896

1,902

1,964

Minority Interest

-6

-7

-6

-8

-4

Net Income

852

1,985

1,890

1,894

1,960

Net Income Growth

-29.41%

+132.98%

-4.79%

+0.21%

+3.48%

Net Income Margin %

13.53%

35.1%

22.14%

19.58%

17.92%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

858

1,997

1,912

1,902

1,969

Basic EPS - Continuing Operations

6.92

16.95

17.19

17.55

18.09

Basic EPS - Continuing Operations Growth

-23.28%

+144.82%

+1.42%

+2.09%

+3.08%

Diluted EPS - Continuing Operations

6.89

16.85

17.06

17.41

18

Diluted EPS - Continuing Operations Growth

-23.02%

+144.56%

+1.25%

+2.05%

+3.39%

Basic Weighted Average Shares Outstanding

123.93

117.82

111.22

108.38

108.85

Diluted Weighted Average Shares Outstanding

124.65

118.48

112.08

109.24

109.38

Dividend Per Share

2.4

2.48

2.72

2.74

2.8

Dividend Per Share Growth

+15.38%

+3.33%

+9.68%

+0.74%

+2.19%

EBITDA

1,369

1,090

2,422

1,985

1,831

EBITDA Growth

-15.13%

-20.38%

+122.2%

-18.04%

-7.76%

EBITDA Margin %

21.74%

19.27%

28.37%

20.52%

16.74%

EBIT